Childhood Migraine Relief: NiPRF vs. Calcium Channel Blockers

Research Summary

A recent study published in Pediatric Neurology explored the effectiveness and safety of noninvasive pulsed radiofrequency (NiPRF) therapy for treating childhood migraines, comparing it with the use of calcium channel blockers (CCBs). Involving 60 children aged 7-18, the trial divided participants into two groups: one receiving flunarizine, a CCB, and the other undergoing NiPRF sessions. Results showed both treatments significantly reduced headache frequency and severity over 3 months, although CCBs showed a greater reduction in headache frequency at 3 months. While some CCB patients faced liver enzyme issues, NiPRF had minimal side effects, indicating its potential as a safe, effective alternative.

Study Details

📄 Title: A Novel Neuromodulation Method for Childhood Migraine: Comparing Noninvasive Pulsed Radiofrequency Therapy With Calcium Channel Blockers, a Randomized Controlled Trial.

👥 Research Team: Üstün C et al.

📚 Published In: Pediatr Neurol

📅 Publication Date: 2025 Dec 29

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.